The TCF4/β-catenin pathway and chromatin structure cooperate to regulate D-glucuronyl C5-epimerase expression in breast cancer

References

• Sarrazin S, Lamanna WC, Esko JD. Heparan sulfate proteoglycans. Cold Spring Harb Perspect Biol 2011; 3; http://dx.doi.org/10.1101/cshperspect.a004952; PMID: 21690215
   PubMed Web of Science ®Google Scholar
• Kim SH, Turnbull J, Guimond S. Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor. J Endocrinol 2011; 209:139 - 51; http://dx.doi.org/10.1530/JOE-10-0377; PMID: 21307119
   PubMed Web of Science ®Google Scholar
• Ori A, Wilkinson MC, Fernig DG. The heparanome and regulation of cell function: structures, functions and challenges. Front Biosci 2008; 13:4309 - 38; http://dx.doi.org/10.2741/3007; PMID: 18508513
   PubMed Web of Science ®Google Scholar
• Malavaki CJ, Theocharis AD, Lamari FN, Kanakis I, Tsegenidis T, Tzanakakis GN, et al. Heparan sulfate: biological significance, tools for biochemical analysis and structural characterization. Biomed Chromatogr 2011; 25:11 - 20; http://dx.doi.org/10.1002/bmc.1536; PMID: 21204109
   PubMed Web of Science ®Google Scholar
• Jia J, Maccarana M, Zhang X, Bespalov M, Lindahl U, Li JP. Lack of L-iduronic acid in heparan sulfate affects interaction with growth factors and cell signaling. J Biol Chem 2009; 284:15942 - 50; http://dx.doi.org/10.1074/jbc.M809577200; PMID: 19336402
   PubMed Web of Science ®Google Scholar
• Catlow KR, Deakin JA, Wei Z, Delehedde M, Fernig DG, Gherardi E, et al. Interactions of hepatocyte growth factor/scatter factor with various glycosaminoglycans reveal an important interplay between the presence of iduronate and sulfate density. J Biol Chem 2008; 283:5235 - 48; http://dx.doi.org/10.1074/jbc.M706589200; PMID: 18156180
   PubMed Web of Science ®Google Scholar
• Chua CC, Rahimi N, Forsten-Williams K, Nugent MA. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2. Circ Res 2004; 94:316 - 23; http://dx.doi.org/10.1161/01.RES.0000112965.70691.AC; PMID: 14684627
   PubMed Web of Science ®Google Scholar
• Reijmers RM, Groen RW, Kuil A, Weijer K, Kimberley FC, Medema JP, et al. Disruption of heparan sulfate proteoglycan conformation perturbs B-cell maturation and APRIL-mediated plasma cell survival. Blood 2011; 117:6162 - 71; http://dx.doi.org/10.1182/blood-2010-12-325522; PMID: 21471524
   PubMed Web of Science ®Google Scholar
• Reijmers RM, Vondenhoff MF, Roozendaal R, Kuil A, Li JP, Spaargaren M, et al. Impaired lymphoid organ development in mice lacking the heparan sulfate modifying enzyme glucuronyl C5-epimerase. J Immunol 2010; 184:3656 - 64; http://dx.doi.org/10.4049/jimmunol.0902200; PMID: 20208005
   PubMed Web of Science ®Google Scholar
• Feyerabend TB, Li JP, Lindahl U, Rodewald HR. Heparan sulfate C5-epimerase is essential for heparin biosynthesis in mast cells. Nat Chem Biol 2006; 2:195 - 6; http://dx.doi.org/10.1038/nchembio777; PMID: 16532012
   PubMed Web of Science ®Google Scholar
• Ghiselli G, Farber SA. D-glucuronyl C5-epimerase acts in dorso-ventral axis formation in zebrafish. BMC Dev Biol 2005; 5:19; http://dx.doi.org/10.1186/1471-213X-5-19; PMID: 16156897
   PubMed Web of Science ®Google Scholar
• Bülow HE, Hobert O. Differential sulfations and epimerization define heparan sulfate specificity in nervous system development. Neuron 2004; 41:723 - 36; http://dx.doi.org/10.1016/S0896-6273(04)00084-4; PMID: 15003172
   PubMed Web of Science ®Google Scholar
• Li JP, Gong F, Hagner-McWhirter A, Forsberg E, Abrink M, Kisilevsky R, et al. Targeted disruption of a murine glucuronyl C5-epimerase gene results in heparan sulfate lacking L-iduronic acid and in neonatal lethality. J Biol Chem 2003; 278:28363 - 6; http://dx.doi.org/10.1074/jbc.C300219200; PMID: 12788935
   PubMed Web of Science ®Google Scholar
• Iozzo RV, Zoeller JJ, Nyström A. Basement membrane proteoglycans: modulators Par Excellence of cancer growth and angiogenesis. Mol Cells 2009; 27:503 - 13; http://dx.doi.org/10.1007/s10059-009-0069-0; PMID: 19466598
   PubMed Web of Science ®Google Scholar
• Eshchenko TY, Rykova VI, Chernakov AE, Sidorov SV, Grigorieva EV. Expression of different proteoglycans in human breast tumors. Biochemistry (Mosc) 2007; 72:1016 - 20; http://dx.doi.org/10.1134/S0006297907090143; PMID: 17922662
   PubMed Web of Science ®Google Scholar
• Grigorieva E, Eshchenko T, Rykova VI, Chernakov A, Zabarovsky ER, Sidorov SV. Decreased expression of human D-glucuronyl C5-epimerase in breast cancer. Int J Cancer 2008; 122:1172 - 6; http://dx.doi.org/10.1002/ijc.23203; PMID: 17985344
   PubMed Web of Science ®Google Scholar
• Grigorieva EV, Prudnikova TY, Domanitskaya NV, Mostovich LA, Pavlova TV, Kashuba VI, et al. D-glucuronyl C5-epimerase suppresses small-cell lung cancer cell proliferation in vitro and tumour growth in vivo. Br J Cancer 2011; 105:74 - 82; http://dx.doi.org/10.1038/bjc.2011.170; PMID: 21654676
   PubMedGoogle Scholar
• Prudnikova TY, Mostovich LA, Domanitskaya NV, Pavlova TV, Kashuba VI, Zabarovsky ER, et al. Antiproliferative effect of D-glucuronyl C5-epimerase in human breast cancer cells. Cancer Cell Int 2010; 10:27; http://dx.doi.org/10.1186/1475-2867-10-27; PMID: 20723247
   PubMed Web of Science ®Google Scholar
• Mostovich LA, Prudnikova TY, Domanitskaya NV, Verzhbitskaya NE, Kharchenko OV, Nepomnyaschikh GI, et al. Molecular mechanisms of anti-tumor effect of D-glucuronyl C5-epimerase in lung cancer experimental model in vivo.. Siber J Oncol 2010; 2:24 - 9
   Google Scholar
• Ghiselli G, Agrawal A. The human D-glucuronyl C5-epimerase gene is transcriptionally activated through the beta-catenin-TCF4 pathway. Biochem J 2005; 390:493 - 9; http://dx.doi.org/10.1042/BJ20050152; PMID: 15853773
   PubMed Web of Science ®Google Scholar
• Lopes CC, Toma L, Pinhal MA, Porcionatto MA, Sogayar MC, Dietrich CP, et al. EJ-ras oncogene transfection of endothelial cells upregulates the expression of syndecan-4 and downregulates heparan sulfate sulfotransferases and epimerase. Biochimie 2006; 88:1493 - 504; http://dx.doi.org/10.1016/j.biochi.2006.04.009; PMID: 16793191
   PubMed Web of Science ®Google Scholar
• Small EM, Sutherland LB, Rajagopalan KN, Wang S, Olson EN. MicroRNA-218 regulates vascular patterning by modulation of Slit-Robo signaling. Circ Res 2010; 107:1336 - 44; http://dx.doi.org/10.1161/CIRCRESAHA.110.227926; PMID: 20947829
   PubMed Web of Science ®Google Scholar
• Sandoval J, Esteller M. Cancer epigenomics: beyond genomics. Curr Opin Genet Dev 2012; 22:50 - 5; http://dx.doi.org/10.1016/j.gde.2012.02.008; PMID: 22402447
   PubMed Web of Science ®Google Scholar
• Mazzio EA, Soliman KF. Basic concepts of epigenetics: impact of environmental signals on gene expression. Epigenetics 2012; 7:119 - 30; http://dx.doi.org/10.4161/epi.7.2.18764; PMID: 22395460
   PubMed Web of Science ®Google Scholar
• Kulis M, Esteller M. DNA methylation and cancer. Adv Genet 2010; 70:27 - 56; http://dx.doi.org/10.1016/B978-0-12-380866-0.60002-2; PMID: 20920744
   PubMed Web of Science ®Google Scholar
• Ropero S, Setien F, Espada J, Fraga MF, Herranz M, Asp J, et al. Epigenetic loss of the familial tumor-suppressor gene exostosin-1 (EXT1) disrupts heparan sulfate synthesis in cancer cells. Hum Mol Genet 2004; 13:2753 - 65; http://dx.doi.org/10.1093/hmg/ddh298; PMID: 15385438
   PubMed Web of Science ®Google Scholar
• Bui C, Ouzzine M, Talhaoui I, Sharp S, Prydz K, Coughtrie MW, et al. Epigenetics: methylation-associated repression of heparan sulfate 3-O-sulfotransferase gene expression contributes to the invasive phenotype of H-EMC-SS chondrosarcoma cells. FASEB J 2010; 24:436 - 50; http://dx.doi.org/10.1096/fj.09-136291; PMID: 19812376
   PubMed Web of Science ®Google Scholar
• Miyamoto K, Asada K, Fukutomi T, Okochi E, Yagi Y, Hasegawa T, et al. Methylation-associated silencing of heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers. Oncogene 2003; 22:274 - 80; http://dx.doi.org/10.1038/sj.onc.1206146; PMID: 12527896
   PubMed Web of Science ®Google Scholar
• Chen Z, Fan JQ, Li J, Li QS, Yan Z, Jia XK, et al. Promoter hypermethylation correlates with the Hsulf-1 silencing in human breast and gastric cancer. Int J Cancer 2009; 124:739 - 44; http://dx.doi.org/10.1002/ijc.23960; PMID: 19006069
   PubMed Web of Science ®Google Scholar
• Xiang YY, Ladeda V, Filmus J. Glypican-3 expression is silenced in human breast cancer. Oncogene 2001; 20:7408 - 12; http://dx.doi.org/10.1038/sj.onc.1204925; PMID: 11704870
   PubMed Web of Science ®Google Scholar
• Kizuka Y, Kitazume S, Yoshida M, Taniguchi N. Brain-specific expression of N-acetylglucosaminyltransferase IX (GnT-IX) is regulated by epigenetic histone modifications. J Biol Chem 2011; 286:31875 - 84; http://dx.doi.org/10.1074/jbc.M111.251173; PMID: 21771782
   PubMed Web of Science ®Google Scholar
• Zhang C, Li H, Zhou G, Zhang Q, Zhang T, Li J, et al. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells. J Pathol 2007; 212:134 - 42; http://dx.doi.org/10.1002/path.2173; PMID: 17471463
   PubMed Web of Science ®Google Scholar
• Zhang C, Li H, Wang Y, Liu W, Zhang Q, Zhang T, et al. Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications. J Hepatol 2010; 53:889 - 95; http://dx.doi.org/10.1016/j.jhep.2010.05.012; PMID: 20675009
   PubMed Web of Science ®Google Scholar
• Kim SK, Jang HR, Kim JH, Kim M, Noh SM, Song KS, et al. CpG methylation in exon 1 of transcription factor 4 increases with age in normal gastric mucosa and is associated with gene silencing in intestinal-type gastric cancers. Carcinogenesis 2008; 29:1623 - 31; http://dx.doi.org/10.1093/carcin/bgn110; PMID: 18635522
   PubMed Web of Science ®Google Scholar
• Foltz G, Yoon JG, Lee H, Ma L, Tian Q, Hood L, et al. Epigenetic regulation of wnt pathway antagonists in human glioblastoma multiforme. Genes Cancer 2010; 1:81 - 90; http://dx.doi.org/10.1177/1947601909356103; PMID: 21779426
   PubMedGoogle Scholar
• Heinz S, Glass CK. Roles of lineage-determining transcription factors in establishing open chromatin: lessons from high-throughput studies. Curr Top Microbiol Immunol 2012; 356:1 - 15; http://dx.doi.org/10.1007/82_2011_142; PMID: 21744305
   PubMed Web of Science ®Google Scholar
• Ravindranath A, Yuen HF, Chan KK, Grills C, Fennell DA, Lappin TR, et al. Wnt-β-catenin-Tcf-4 signalling-modulated invasiveness is dependent on osteopontin expression in breast cancer. Br J Cancer 2011; 105:542 - 51; http://dx.doi.org/10.1038/bjc.2011.269; PMID: 21772333
   PubMed Web of Science ®Google Scholar
• Wöhrle S, Wallmen B, Hecht A. Differential control of Wnt target genes involves epigenetic mechanisms and selective promoter occupancy by T-cell factors. Mol Cell Biol 2007; 27:8164 - 77; http://dx.doi.org/10.1128/MCB.00555-07; PMID: 17923689
   PubMed Web of Science ®Google Scholar
• Kikuchi A, Yamamoto H, Sato A, Matsumoto S. New insights into the mechanism of Wnt signaling pathway activation. Int Rev Cell Mol Biol 2011; 291:21 - 71; http://dx.doi.org/10.1016/B978-0-12-386035-4.00002-1; PMID: 22017973
   PubMed Web of Science ®Google Scholar
• Sakane H, Yamamoto H, Matsumoto S, Sato A, Kikuchi A. Localization of glypican-4 in different membrane microdomains is involved in the regulation of Wnt signaling. J Cell Sci 2012; 125:449 - 60; http://dx.doi.org/10.1242/jcs.091876; PMID: 22302992
   PubMed Web of Science ®Google Scholar
• Cadwalader EL, Condic ML, Yost HJ. 2-O-sulfotransferase regulates Wnt signaling, cell adhesion and cell cycle during zebrafish epiboly. Development 2012; 139:1296 - 305; http://dx.doi.org/10.1242/dev.078238; PMID: 22357927
   PubMed Web of Science ®Google Scholar
• Rodríguez-Paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology. Nat Med 2011; 17:330 - 9; http://dx.doi.org/10.1038/nm.2305; PMID: 21386836
   PubMed Web of Science ®Google Scholar
• Lustberg MB, Ramaswamy B. Epigenetic targeting in breast cancer: therapeutic impact and future direction. Drug News Perspect 2009; 22:369 - 81; http://dx.doi.org/10.1358/dnp.2009.22.7.1405072; PMID: 19890494
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Nielsen HM, Hansen LL. Epigenetics and cancer treatment. Eur J Pharmacol 2009; 625:131 - 42; http://dx.doi.org/10.1016/j.ejphar.2009.10.011; PMID: 19836388
   PubMed Web of Science ®Google Scholar